Trulicity 0.75 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6Y1L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,749
Award facts
- Contract value 100% obligated
- $10,749.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a $10,749.31 delivery order by the Defense Logistics Agency (DLA) on January 27, 2026, for the supply of Trulicity 0.75 mg/0.5 mL pen injections. This firm fixed-price, non-set-aside contract is scheduled for completion by January 28, 2026, with performance based in Conshohocken, Pennsylvania. The delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Trulicity is a diabetes management medication, and this delivery order exemplifies Amerisourcebergen's role as a critical pharmaceutical distributor for federal medical procurement. The company's competitively awarded contract portfolio demonstrates its capability to supply a diverse range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations, U.S. Coast Guard, and other federal healthcare systems. The non-set-aside status of this award reflects the company's ability to compete on a full and open basis for federal pharmaceutical procurement requirements.
Quick answers
Who was awarded contract SPE2DR26F6Y1L?
SPE2DR26F6Y1L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F6Y1L worth?
The government has obligated $10,749 on SPE2DR26F6Y1L.
Is contract SPE2DR26F6Y1L an order under another contract?
Yes. SPE2DR26F6Y1L is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6Y1L competed?
The extent of competition for SPE2DR26F6Y1L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award